| Literature DB >> 35675930 |
Yi-Jie Zhang1, Yan Zhu1, Li Zhu1, Cheng-Qiu Lu1, Chao Chen1, Lin Yuan1.
Abstract
OBJECTIVES: To investigate the prevalence of preterm birth (PTB) and the risk factors for different gestational age subgroups of preterm birth in China.Entities:
Keywords: pregnancy; prenatal care; preterm birth; risk factors
Mesh:
Year: 2022 PMID: 35675930 PMCID: PMC9389891 DOI: 10.15537/smj.2022.43.6.20220210
Source DB: PubMed Journal: Saudi Med J ISSN: 0379-5284 Impact factor: 1.422
Figure 1- Flowchart showing the recruitment process for participants.
General characteristics of the study group.
| Characteristics | Total group (n=215254) | Preterm group (n=15833) | Term group (n=199421) |
|
| Gestational age (weeks)
| 38±2 | 34±2 | 39±1 | <0.001 |
| Birth weight (g)
| 3262±500 | 2419±583 | 3329±4263 | <0.001 |
| Male
| 114084 (53.0) | 9212 (58.0) | 105094 (52.7) | 0.001 |
| Maternal age (years)
| 27.4±4.9 | 27.7±5.6 | 27.4±4.8 | <0.001 |
|
| #x00A0; | #x00A0; | #x00A0; | <0.001 |
| 1 | 149951 (69.7) | 9949 (62.8) | 140002 (70.2) | #x00A0; |
| ≥2 | 65303 (30.3) | 5884 (37.2) | 59419 (29.8) | #x00A0; |
| Apgar score at 5 min of <7 | 600 (2.8) | 335 (2.1) | 265 (1.3) | <0.001 |
Mean±SD, p<0.05 was considered significant.
n (%), p<0.05 was considered significant.
- Univariate and multivariate analyses of risk factors for singleton preterm births.
| Factors | Singleton preterm(n=15833) | Singleton term(n=199421) | OR (95% CI)
|
| aOR (95% CI) (Model A)† |
|
|---|---|---|---|---|---|---|
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | |
| <20 | 609 (3.8) | 4584 (2.3) | 1.796 (1.647–1.958) | <0.001 | 1.963 (1.796–2.145) | <0.001 |
| 20–34 | 13124 (82.9) | 177395 (89.0) | 1.000 | #x00A0; | 1.000 | #x00A0; |
| ≥35 | 2100 (13.3) | 17442 (8.7) | 1.627 (1.550–1.708) | <0.001 | 1.318 (1.250–1.390) | <0.001 |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| 1 | 9949 (62.8) | 140002 (70.2) | 1.000 | #x00A0; | 1.000 | #x00A0; |
| ≥2 | 5884 (37.2) | 59419 (29.8) | 1.393 (1.347–1.441) | <0.001 | 1.423 (1.372–1.476) | <0.001 |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes | 1007 (6.4) | 3486 (1.7) | 3.818 (3.552–4.103) | <0.001 | 3.978 (3.691–4.288) | <0.001 |
| No | 14826 (93.6) | 195935 (98.3) | 1.000 | #x00A0; | 1.000 | #x00A0; |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes | 723 (4.6) | 7020 (3.5) | 1.311 (1.213–1.418) | <0.001 | 1.216 (1.122–1.319) | <0.001 |
| No | 15110 (95.4) | 192401 (96.5) | 1.000 | #x00A0; | 1.000 | #x00A0; |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes | 347 (2.2) | 973 (0.5) | 4.570 (4.039–5.172) | <0.001 | 5.520 (4.860–6.270) | <0.001 |
| No | 15486 (97.8) | 198448 (99.5) | 1.000 | #x00A0; | 1.000 | #x00A0; |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes | 288 (1.8) | 2407 (1.2) | 1.516 (1.341–1.71) | <0.001 | 1.261 (1.108–1.436) | <0.001 |
| No | 15545 (98.2) | 199421 (98.2) | 1.000 | #x00A0; | 1.000 | #x00A0; |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | |
| Yes | 196 (1.2) | 787 (0.4) | 3.164 (2.703–3.703) | <0.001 | 2.834 (2.406–3.340) | <0.001 |
| No | 15637 (98.8) | 198634 (99.6) | 1.000 | #x00A0; | 1.000 | #x00A0; |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes | 284 (1.8) | 392 (0.2) | 9.27 (7.95–10.81) | <0.001 | 10.09 (8.60–11.83) | <0.001 |
| No | 15549 (98.2) | 199029 (99.8) | 1.00 | #x00A0; | 1.00 | #x00A0; |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | |
| Yes | 96 (0.6) | 66 (0.0) | 18.42 (13.46–25.21) | <0.001 | 17.20 (12.35–23.95) | <0.001 |
| No | 15737 (99.4) | 199355 (100.0) | 1.000 | #x00A0; | 1.000 | #x00A0; |
| Fetal distress | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes | 832 (5.3) | 8018 (4.0) | 1.324 (1.230–1.425) | <0.001 | 1.249 (1.157–1.348) | <0.001 |
| No | 15001 (94.7) | 191403 (96.0) | 1.000 | #x00A0; | 1.000 | #x00A0; |
Values are presented as number and percentages (%).
OR (odds ratio) value and 95% CI (confidence interval) of univariate logistic analysis model, p<0.05 was considered significant. †aOR (adjusted odds ratio) value and 95% CI after adjusting for other confounders in Model A (including maternal age, parity, HDP, GDM, ICP, anemia, chorioamnionitis, placenta previa, placental abruption, and fetal distress); p<0.05 was considered significant. HDP: hypertension disorders in pregnancy, ICP: intrahepatic cholestasis of pregnancy, GDM: gestational diabetes mellitus
Risk factors associated with each preterm subgroup compared to the term group in multinomial multivariate logistic regression analysis.
| #x00A0; | <32 weeks | #x00A0; | 32–33 weeks | #x00A0; | 34–36 weeks | #x00A0; |
|---|---|---|---|---|---|---|
| Factors | aOR (95% CI)
|
| aOR (95% CI)
|
| aOR (95% CI)
|
|
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | |
| <20 |
| <0.001 |
| <0.001 |
| <0.001 |
| 20–34 | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
| ≥35 |
| <0.001 |
| 0.020 |
| <0.001 |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| 1 | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
| ≥2 |
| <0.001 |
| <0.001 |
| <0.001 |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes |
| <0.001 |
| <0.001 |
| <0.001 |
| No | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes | 1.113 (0.886–1.399) | 0.358 | 1.092 (0.893–1.336) | 0.392 |
| <0.001 |
| No | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes | 1.384 (0.766–2.499) | 0.282 |
| <0.001 |
| <0.001 |
| No | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | |
| Yes | 1.240 (0.896–1.715) | 0.195 |
| 0.001 | 1.096 (0.939–1.279) | 0.246 |
| No | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | |
| Yes |
| <0.001 |
| <0.001 |
| <0.001 |
| No | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | |
| Yes |
| <0.001 |
| <0.001 |
| <0.001 |
| No | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.00 | #x00A0; |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | |
| Yes |
| <0.001 |
| <0.001 |
| <0.001 |
| No | 1.000 | #x00A0; | 1.00 | #x00A0; | 1.00 | #x00A0; |
| Fetal distress | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes |
| <0.001 |
| <0.001 |
| 0.201 |
| No | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
aOR (adjusted odds ration) value and 95% CI (confidence interval) after adjusting for other confounders in Model B (including maternal age, parity, HDP, GDM, ICP, anemia, chorioamnionitis, placenta previa, placental abruption, and fetal distress). The reference group was the term group. P<0.05 was considered significant. Bold values are significant. Bold numbers are significant. HDP: hypertension disorders in pregnancy, ICP: intrahepatic cholestasis of pregnancy, GDM: gestational diabetes mellitus
Risk factors associated with each spontaneous preterm subgroup compared to the term group in multinomial multivariate logistic regression analysis.
| #x00A0; | <32 weeks | #x00A0; | 32–33 weeks | #x00A0; | 34–36 weeks | #x00A0; |
|---|---|---|---|---|---|---|
| Factors | aOR (95% CI)
|
| aOR (95% CI)
|
| aOR (95% CI)
|
|
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| <20 | 1.088 (0.757–1.564) | 0.649 | 1.328 (1.004–1.756) | 0.047 | 0.950 (0/868–1.163) | 0.950 |
| 20–34 | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
| ≥35 |
| <0.001 |
| <0.001 |
| <0.001 |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| 1 | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
| ≥2 |
| <0.001 |
| <0.001 |
| <0.001 |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes |
| <0.001 |
| <0.001 |
| <0.001 |
| No | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes | 1.185 (0.922–1.523) | 0.184 |
| 0.017 |
| <0.001 |
| No | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes | 1.384 (0.766–2.499) | 0.282 |
| <0.001 |
| <0.001 |
| No | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes | 1.240 (0.896–1.715) | 0.195 |
| 0.001 | 1.221 (1.027–1.452) | 0.240 |
| No | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
| Chorioamnionitis | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes |
| <0.001 |
| <0.001 |
| <0.001 |
| No | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes |
| <0.001 |
| <0.001 |
| <0.001 |
| No | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.00 | #x00A0; |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes |
| <0.001 |
| <0.001 |
| <0.001 |
| No | 1.000 | #x00A0; | 1.00 | #x00A0; | 1.00 | #x00A0; |
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes |
| <0.001 |
| <0.001 |
| 0.004 |
| No | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
aOR (adjusted odds ration) value and 95% CI (confidence interval) after adjusting for other confounders in Model B (including maternal age, parity, HDP, GDM, ICP, anemia, chorioamnionitis, placenta previa, placental abruption, and fetal distress); the reference group was the term group. P<0.05 was considered significant. Bold values are significant. HDP: hypertension disorders in pregnancy, ICP: intrahepatic cholestasis of pregnancy, GDM: gestational diabetes mellitus
- Risk factors associated with each iatrogenic preterm subgroup compared to the term group in multinomial multivariate logistic regression analysis.
| #x00A0; | <32 weeks | #x00A0; | 32–33 weeks | #x00A0; | 34–36 weeks | #x00A0; |
|---|---|---|---|---|---|---|
| Factors | aOR (95% CI)
|
| aOR (95% CI)
|
| aOR (95% CI)
|
|
| Maternal age (years) | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| <20 | 2.103 (1.663–2.660) | <0.001 | 2.221 (1.826–2.701) | <0.001 | 1.449 (1.299–1.615) | <0.001 |
| 20–34 | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
| ≥35 | 1.390 (1.207–1.600) | <0.001 | 1.161 (1.018–1.324) | 0.027 | 1.198 (1.126–1.274) | 0.001 |
| Parity | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| 1 | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
| ≥2 | 1.331 (1.238–1.514) | <0.001 | 1.287 (1.177–1.406) | <0.001 | 1.181(1.133–1.231) | <0.001 |
| HDP | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes | 3.405 (2.799–4.143) | <0.001 | 4.176 (3.566–4.892) | <0.001 | 2.900 (2.655–3.168) | <0.001 |
| No | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
| GDM | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes | 1.119 (0.889–1.408) | 0.339 | 1.098 (0.896–1.347) | 0.368 | 1.162 (1.059–1.274) | 0.001 |
| No | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
| ICP | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes | 1.280 (0.709–2.312) | 0.413 | 2.775 (1.949–3.950) | <0.001 | 5.299 (4.646–6.044) | <0.001 |
| No | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
| Anemia | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes | 1.235 (0.891–1.711) | 0.204 | 1.575 (1.199–2.070) | 0.001 | 1.092 (0.935–1.275) | 0.269 |
| No | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
| Chorioamnionitis | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes | 11.89 (9.391–15.07) | <0.001 | 3.317 (2.319–4.743) | <0.001 | 2.025 (1.630–2.516) | <0.001 |
| No | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
| Placenta previa | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes | 3.786 (1.682–8.523) | 0.001 | 1.228 (0.305–4.940) | 0.773 | 2.276 (1.398–3.706) | 0.001 |
| No | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.00 | #x00A0; |
| Placental abruption | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes | 23.68 (10.21–654.9) | <0.001 | 11.236 (23.52–35.87) | <0.001 | 2.404(0.755–7.654) | 0.138 |
| No | 1.000 | #x00A0; | 1.00 | #x00A0; | 1.00 | #x00A0; |
| Fetal distress | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; | #x00A0; |
| Yes | 1.487 (1.230–1.799) | <0.001 | 1.479 (1.263–1.779) | <0.001 | 1.071 (0.978–1.173) | 0.141 |
| No | 1.000 | #x00A0; | 1.000 | #x00A0; | 1.000 | #x00A0; |
aOR (adjusted odds ration) value and 95% CI (confidence interval) after adjusting for other confounders in Model B (including maternal age, parity, HDP, GDM, ICP, anemia, chorioamnionitis, placenta previa, placental abruption, and fetal distress); the reference group was the term group. P<0.05 was considered significant. Bold values are significant. HDP: hypertension disorders in pregnancy, ICP: intrahepatic cholestasis of pregnancy, GDM: gestational diabetes mellitus.
Distribution of the risk factors in each group.
| Variables | <32 weeks(n=1703) | 32–33 weeks(n=2345) | 34–36 weeks(n=11785) | 37–41 weeks(199421) |
|
|---|---|---|---|---|---|
|
| #x00A0; | #x00A0; | #x00A0; | #x00A0; | <0.001 |
| <20 | 83 (4.9) | 123 (5.2) | 403 (3.4) | 4584 (2.3) | #x00A0; |
| 20–34 | 1345 (79.0) | 1915 (81.7) | 9864 (83.7) | 177395 (89.0) | #x00A0; |
| ≥35 | 275 (16.1) | 307 (13.1) | 1518 (12.9) | 17442 (8.7) | #x00A0; |
| Parity ≥ 2 | 704 (41.3) | 905 (38.6) | 4275 (36.3) | 59419 (29.8) | <0.001 |
| HDP | 119 (7.0) | 182 (7.8) | 706 (6.0) | 3486 (1.7) | <0.001 |
| GDM | 76 (4.5) | 100 (4.3) | 547 (4.6) | 7020 (3.5) | <0.001 |
| ICP | 12 (0.7) | 38 (1.6) | 297 (2.5) | 1973 (0.5) | <0.001 |
| Anemia | 37 (2.2) | 61 (2.6) | 190 (1.6) | 2407 (1.2) | <0.001 |
| Chorioamnionitis | 48 (2.8) | 35 (1.5) | 113 (1.0) | 787 (0.4) | <0.001 |
| Placenta previa | 47 (2.8) | 46 (2.0) | 191 (1.6) | 6392 (0.2) | <0.001 |
| Placental abruption | 24 (1.4) | 26 (1.1) | 46 (0.4) | 66 (0.0) | <0.001 |
| Fetal distress | 124 (7.3) | 166 (7.1) | 542 (4.6) | 80718 (4.0) | <0.001 |
Values are presented as number and percentages (%).
P-value indicates results of χ2 test comparing proportions of the distribution of risk factors for preterm subgroups. HDP: hypertension disorders in pregnancy, ICP: intrahepatic cholestasis of pregnancy, GDM: gestational diabetes mellitus